Shi, Xiaoxin http://orcid.org/0000-0003-0739-7189
Sutherland, Kate
Lobbezoo, Frank
Berkhout, Erwin
de Lange, Jan
Cistulli, Peter A.
Darendeliler, M. Ali
Dalci, Oyku
Aarab, Ghizlane
Funding for this research was provided by:
National Health and Medical Research Council (GNT1024351)
China Scholarship Council
Article History
Received: 11 July 2022
Revised: 19 June 2023
Accepted: 23 June 2023
First Online: 19 July 2023
Declarations
:
: This study received ethical approval (Sydney Local Health District, Protocol No. X11-0134 & HREC/11/RPAH/192).
: Informed consent was obtained from all individual participants included in the study.
: Xiaoxin Shi declares that she has no conflicts of interest. Kate Sutherland has received in kind support from SomnoMed Australia in the form of donation of oral appliances for investigator-initiated research. Frank Lobbezoo is a member of the Academic Advisory Boards for GrindCare and Oral Function of Sunstar Suisse S.A. and receives research grants from Sunstar Suisse S.A., SomnoMed, Vivisol BV, Health Holland, and Airway Management. Erwin Berkhout declares that he has no conflicts of interest. Jan de Lange declares that he has no conflicts of interest. Peter A. Cistulli holds the ResMed Chair in Sleep Medicine at the University of Sydney, established through funding from ResMed. He is a consultant to ResMed, SomnoMed, and Signifier Medical Technologies and has receive equipment support for research. M. Ali Darendeliler declares that he has no conflicts of interest. Oyku Dalci declares that she has no conflicts of interest. Ghizlane Aarab is a member of the Academic Advisory Board for Oral Function of Sunstar Suisse S.A. and receives research grants from Sunstar Suisse S.A., SomnoMed, Vivisol BV, and Health Holland.